NanoViricides Inc. (NNVC)

[changes_iv]

JG36...I had a question and you take upon yourself to reply with...another question??? Never mind. Batches (plural) has to do with cGMP. NanoViricides, Inc. is not there yet but it will be 4Q 2013, soon. Those cGMP batches will be identical (tight tolerances).

"The Company will be able to initiate GLP Safety/Toxicology studies (“Tox Package”) studies of the injectable FluCide drug when the requisite large amount of drug substance is produced." That may have happened already and I speculate released to us along with a "big board" announcement.

Announcing that "tox studies" have begun, all by itself, only indicates that the "train is moving" on-track to deliver, as expected, positive toxicology "initial results" on injectable FluCide, 4Q 2013. And that would be that.

When the cGMP plant is completely integrated, the batch of candidate drug product to be used in the human trials will likely be the same as that used in the toxicology studies. NanoViricides, Inc. will be making identical batches of that injectable FluCide.

I therefore think we are now waiting for the up-list to the "big board" NYSE MKT LLC PR, which I believe will also include a statement that "GLP Safety/Toxicology studies (“Tox Package”) studies of the injectable FluCide drug were initiated..." and then we are off to the races! I am speculating, and vested with NNVC. I'm trying to persuade others to join in. I enjoy reading posts here, even persuasive contrarian ones.